Subject
Cardiology and Cardiovascular Medicine
Reference5 articles.
1. Santé Canada. Ligne directrice—normes en matière d'études de biodisponibilités comparatives : Formes pharmaceutiques de médicaments à effets systémiques Médicaments et produits de santé. 2018. https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/biodisponibilite-bioequivalence/normes-matiere-etudes-biodisponibilite-comparatives-formes-pharmaceutiques-medicaments-effets-systemiques.html. Accessed April 23, 2020.
2. Did generic clopidogrel commercialization affect trends of er consultations and hospitalizations in the population treated with clopidogrel?;Leclerc;Drugs Aging,2019
3. Impact of the commercialization of three generic angiotensin ii receptor blockers on adverse events in Quebec, Canada: a population-based time series analysis;Leclerc;Circ Cardiovasc Quality Outcomes,2017
4. Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis;Leclerc;Drugs,2020
5. Backlash over meat dietary recommendations raises questions about corporate ties to nutrition scientists;Rubin;JAMA,2020